UniProt ID | HMGN3_HUMAN | |
---|---|---|
UniProt AC | Q15651 | |
Protein Name | High mobility group nucleosome-binding domain-containing protein 3 | |
Gene Name | HMGN3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 99 | |
Subcellular Localization | Nucleus. | |
Protein Description | Binds to nucleosomes, regulating chromatin structure and consequently, chromatin-dependent processes such as transcription, DNA replication and DNA repair. Affects both insulin and glucagon levels and modulates the expression of pancreatic genes involved in insulin secretion. Regulates the expression of the glucose transporter SLC2A2 by binding specifically to its promoter region and recruiting PDX1 and additional transcription factors. Regulates the expression of SLC6A9, a glycine transporter which regulates the glycine concentration in synaptic junctions in the central nervous system, by binding to its transcription start site. May play a role in ocular development and astrocyte function (By similarity).. | |
Protein Sequence | MPKRKSPENTEGKDGSKVTKQEPTRRSARLSAKPAPPKPEPKPRKTSAKKEPGAKISRGAKGKKEEKQEAGKEGTAPSENGETKAEEAQKTESVDNEGE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MPKRKSPENTEGK --CCCCCCCCCCCCC | 41.29 | 22167270 | |
6 (in isoform 2) | Phosphorylation | - | 41.29 | - | |
10 | Phosphorylation | KRKSPENTEGKDGSK CCCCCCCCCCCCCCC | 44.44 | 28176443 | |
10 (in isoform 2) | Phosphorylation | - | 44.44 | - | |
13 (in isoform 2) | Ubiquitination | - | 53.32 | 21906983 | |
13 (in isoform 1) | Ubiquitination | - | 53.32 | 21906983 | |
13 | Acetylation | SPENTEGKDGSKVTK CCCCCCCCCCCCCCC | 53.32 | 23954790 | |
13 | Ubiquitination | SPENTEGKDGSKVTK CCCCCCCCCCCCCCC | 53.32 | 21906983 | |
16 | Phosphorylation | NTEGKDGSKVTKQEP CCCCCCCCCCCCCCC | 33.80 | 24732914 | |
17 | Acetylation | TEGKDGSKVTKQEPT CCCCCCCCCCCCCCC | 60.50 | 26051181 | |
19 | Phosphorylation | GKDGSKVTKQEPTRR CCCCCCCCCCCCCHH | 30.65 | 24719451 | |
27 | Phosphorylation | KQEPTRRSARLSAKP CCCCCHHHHHHCCCC | 17.91 | 25159151 | |
27 (in isoform 2) | Phosphorylation | - | 17.91 | - | |
31 | Phosphorylation | TRRSARLSAKPAPPK CHHHHHHCCCCCCCC | 28.79 | 23401153 | |
31 (in isoform 2) | Phosphorylation | - | 28.79 | - | |
33 | Acetylation | RSARLSAKPAPPKPE HHHHHCCCCCCCCCC | 38.03 | 19608861 | |
33 (in isoform 2) | Acetylation | - | 38.03 | - | |
33 | Ubiquitination | RSARLSAKPAPPKPE HHHHHCCCCCCCCCC | 38.03 | 19608861 | |
38 | Ubiquitination | SAKPAPPKPEPKPRK CCCCCCCCCCCCCCC | 62.04 | 19608861 | |
38 | Sumoylation | SAKPAPPKPEPKPRK CCCCCCCCCCCCCCC | 62.04 | - | |
38 (in isoform 2) | Acetylation | - | 62.04 | - | |
38 | Acetylation | SAKPAPPKPEPKPRK CCCCCCCCCCCCCCC | 62.04 | 19608861 | |
38 | Sumoylation | SAKPAPPKPEPKPRK CCCCCCCCCCCCCCC | 62.04 | 19608861 | |
55 (in isoform 2) | Ubiquitination | - | 47.32 | 21906983 | |
55 (in isoform 1) | Ubiquitination | - | 47.32 | 21906983 | |
55 | Acetylation | AKKEPGAKISRGAKG CCCCCCCCCCCCCCC | 47.32 | 25953088 | |
55 | Ubiquitination | AKKEPGAKISRGAKG CCCCCCCCCCCCCCC | 47.32 | 21906983 | |
57 | Phosphorylation | KEPGAKISRGAKGKK CCCCCCCCCCCCCCH | 24.77 | 29496963 | |
72 | Acetylation | EEKQEAGKEGTAPSE HHHHHHCCCCCCCCC | 61.08 | 26051181 | |
75 | Phosphorylation | QEAGKEGTAPSENGE HHHCCCCCCCCCCCC | 36.16 | 30266825 | |
78 | Phosphorylation | GKEGTAPSENGETKA CCCCCCCCCCCCCHH | 41.03 | 29255136 | |
83 | Phosphorylation | APSENGETKAEEAQK CCCCCCCCHHHHHHH | 36.63 | 30266825 | |
84 | Ubiquitination | PSENGETKAEEAQKT CCCCCCCHHHHHHHH | 49.88 | - | |
84 | Acetylation | PSENGETKAEEAQKT CCCCCCCHHHHHHHH | 49.88 | 26051181 | |
90 | Ubiquitination | TKAEEAQKTESVDNE CHHHHHHHHHCCCCC | 62.40 | 19608861 | |
90 (in isoform 1) | Ubiquitination | - | 62.40 | 21906983 | |
90 | Acetylation | TKAEEAQKTESVDNE CHHHHHHHHHCCCCC | 62.40 | 19608861 | |
91 | Phosphorylation | KAEEAQKTESVDNEG HHHHHHHHHCCCCCC | 22.78 | 23401153 | |
93 | Phosphorylation | EEAQKTESVDNEGE- HHHHHHHCCCCCCC- | 39.75 | 29255136 | |
103 | Phosphorylation | NEGE----------- CCCC----------- | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HMGN3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HMGN3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HMGN3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of HMGN3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-33; LYS-38 AND LYS-90, ANDMASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-93, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-31 AND SER-93,AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-10, AND MASSSPECTROMETRY. |